As of April 16, 2025, Janux Therapeutics (JANX) has a market cap of $1.72 billion USD. According to our data, Janux Therapeutics is ranked No.4214 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $1.72 B |
-45.29%
|
Dec 31, 2024 | $3.14 B |
398.97%
|
Dec 29, 2023 | $0.63 B |
-18.53%
|
Dec 30, 2022 | $0.77 B |
-33.25%
|
Dec 31, 2021 | $1.16 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Fate Therapeutics
FATE
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() Iovance Biotherapeutics
IOVA
|
$1.06 B |
-0.000 M
|
![]() USA
|
![]() Adaptimmune Therapeutics
ADAP
|
$64.18 M |
-0.000 M
|
![]() UK
|
![]() Atara Biotherapeutics
ATRA
|
$35.04 M |
-0.000 M
|
![]() USA
|
![]() Allogene Therapeutics
ALLO
|
$0.32 B |
0.000 M
|
![]() USA
|
![]() Poseida Therapeutics
PSTX
|
$0.93 B |
0.000 M
|
![]() USA
|
![]() Cellectis
CLLS
|
$0.18 B |
36.593 M
|
![]() France
|
![]() Autolus Therapeutics
AUTL
|
$0.37 B |
-0.000 M
|
![]() UK
|
![]() Gritstone bio
GRTS
|
$3.80 M |
2.350 M
|
![]() USA
|
![]() Precision BioSciences
DTIL
|
$57.86 M |
0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
![]() USA
|
Market Cap | = | JANX Stock Price | * | JANX Shares Outstanding |
= | $29.06 | * | 59.11 M | |
= | $1.72 B |